title: [Construction of a SV40 promoter specific artificial transcription factor].
abstract: Transcriptions are regulated by transcription factors. Natural transcription factors usually consist of at least two functional domains: a DNA-binding domain and an effector domain. According to this, novel artificial transcription factors are designed to up or down regulate transcription and expression of a target gene. The Cys2-His2 zinc finger domain is a DNA-binding module that has been widely used as the DNA-binding domain in artificial transcription factors. Each zinc finger domain, which comprises about 30 amino acids that adopt a compact structure by chelating a zinc ion, typically functions by binding 3 base pairs of DNA sequence. Several zinc fingers linked together would bind proportionally longer DNA sequences. According to the "bipartite complementary" library strategy, a pair of zinc finger phage display libraries were constructed. After construction of the libraries, a 9bp sequence (5'-GCAGAGGCC-3') on the promoter of SV40 was chosen as a target for next step. After parallel selection, PCR amplification, desired fragments recovery, re-ligation, and additional rounds of selection, phage enzyme-linked ELISA experiments were performed to identify specific binding clones displaying the zinc fingers with predetermined sequence-specificity to our target sequence. Then two clones with strong ELISA signals were chosen to be tested for binding both to its full target site (5'-GCAGAGGCC-3') and to sites containing single transition mutations. The binding specificity of one of the two clones (clone 3) was shown to be fairly good. The three-finger DNA-binding domain targeted to SV40 promoter, that is, zinc finger sequences on clone 3, was fused to KOX1 suppression domain KRAB and cloned into pcDNA3.1 (+) (which expression product was artificial transcription factor). The zinc fingers (which expression product was the DNA-binding domain of artificial transcription factor) and KRAB domain only (which expression product was effector domain of artificial transcription factor) were also cloned separately into the same expression vector. All constructs contained an N-terminal nuclear localization signal. Every of the vectors (including pcDNA3.1 (+) without inserting sequences) were cotransfected with pGL3-Control and pRL-TK and the activity of luciferase was used to indicate the function of product from transfected expression vectors. Our artificial transcription factor was proved to repress the expression of reporter gene efficiently,while with only DNA-binding domain or effector domain the repression was not remarkable. By adding different effector domains and changing the DNA-binding domain, artificial transcription factor would have a wide range of potential applications.
authors.affiliation: Beijing Institute of Biotechnology, Beijing 100071, China.
authors.forename: Xing-Hui
authors.initials: XH
authors.lastname: Zhao
authors.forename: Xu-Dong
authors.initials: XD
authors.lastname: Zhu
authors.forename: Juan
authors.initials: J
authors.lastname: Liu
authors.forename: Xiang-Jun
authors.initials: XJ
authors.lastname: Rao
authors.forename: Pei-Tang
authors.initials: PT
authors.lastname: Huang
mesh_terms: D004797:Enzyme-Linked Immunosorbent Assay; D005813:Genes, Synthetic / Q000235:genetics / Q000502:physiology*; D008962:Models, Theoretical; D019151:Peptide Library; D016133:Polymerase Chain Reaction; D011401:Promoter Regions, Genetic / Q000235:genetics*; D014157:Transcription Factors / Q000138:chemical synthesis / Q000737:chemistry / Q000378:metabolism*; D016335:Zinc Fingers / Q000235:genetics / Q000502:physiology
chemical_list: D019151:Peptide Library; D014157:Transcription Factors